Author Archive: George Goodno

George Goodno

George is the Director of State Policy Communications at BIO and enjoys the opportunity to advocate for and educate audiences about the positive societal and economic impact of the bioscience industry. Another great aspect of his job is getting to work with BIO’s broad network of state bioscience associations to help advance legislative and regulatory initiatives that will continue to improve this high-skill, high-wage industry. In his spare time, he enjoys running, skiing, hiking, gardening, and most of all, spending time with his awesome wife and two daughters.

Follow him on Twitter @ggoodno

 

Latest Posts

Biotechnology Mending Broken Hearts

Biotech-stem-cell-hearts

It’s been just over 15 years since James Thomson first isolated embryonic stem cells in his lab at the University of Wisconsin-Madison. In that time, some remarkable advances have been made. Namely, I’m talking about the ability to transform adult human cells into extremely useful pluripotent stem cells. A new treatment using pluripotent cells could potentially repair and regenerate damaged heart tissue. In a 2013 study published in The Lancet, Dr. Eduardo Marban, director of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

A New Addition to Pennsylvania Bio’s Leadership Team

ct-115x76

To effectively achieve our mission as the champion and advocate of biotechnology, BIO works with a broad network of organizations. Foremost among these relationships are the ones we possess with a broad network of state-based organizations known as the Council of State Bioscience Associations (CSBA). Pennsylvania Bio (PA Bio) has been a key ally to BIO and vocal advocate for state and federal public policy in support of the biotechnology industry since our inception. Just Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Chicago Gets A New Health Care Incubator

Governor Pat Quinn is joined by civic and business leaders to announce MATTER - a new startup center for next-generation healthcare technology companies.

Illinois Governor Pat Quinn announced yesterday details about a new facility to support startup companies researching next-generation biopharma technology. The not-for-profit incubator, called MATTER, was a priority in the Governor’s 2014 State of the State address. The project is part of Governor Quinn’s funding package, administered through the Illinois Department of Commerce and Economic Opportunity (DCEO), that consists of a $2.5 million state investment and a loan of $1.5 million. Business leaders are also raising Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Testifies Before The Michigan Bioscience Caucus

admin-ajax

BIO‘s Senior Policy Consultant, Peter Pellerito, recently testified before the Michigan Legislature’s Bioscience Caucus on economic development initiatives that support the growth of the bioscience industry. As part of the testimony, Pellerito discussed state legislative capital formation and R&D legislative strategies that support technology transfer and industry growth within state borders. Read the transcript of the testimony here.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

Report Shows World’s Weakest IP Environments

admin-ajax

There is clear link between a country’s rate of economic development and the strength of its intellectual property laws. This is particularly true in knowledge-intensive sectors such as biopharmaceuticals. The good news is that some mature and emerging economies are making growing use of patent systems to facilitate biotechnology research and commercialization. The bad news is that a number of countries, including India, China, Brazil and Canada, have established bureaucratic and burdensome hurdles to patentability. Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,